Manual of Nonpharmacological Control of Hypertension:
The prevention and correction of high blood pressure obviously is not an end in itself but a means of preventing cardiovascular complications. It is tempting to res ort to antihypertensive drugs, for the simple reason that current preparations are easy to dose and to take. There is a variety of reas...
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Berlin, Heidelberg
Springer Berlin Heidelberg
1990
|
| Schlagworte: | |
| Online-Zugang: | DE-355 Volltext |
| Zusammenfassung: | The prevention and correction of high blood pressure obviously is not an end in itself but a means of preventing cardiovascular complications. It is tempting to res ort to antihypertensive drugs, for the simple reason that current preparations are easy to dose and to take. There is a variety of reasons, however, to take advantage of the antihypertensive potential of nonpharmaco logical approaches first. For one thing, the use of tablets tends to accentuate the negative effects oflabelling a subject as hypertensive. The act oftaking tablets per se may elicit a spectrum of subjective adverse effects, as we have learned from placebo-controlled therapeutic trials. Even more importantly, the benefits of antihypertensive drug treatment are largely confined to the reduction of stroke and disease of the large vessels. With regard to incidence of cardiac events, some modest beneficial effects have been registered, such as a decrease in congestive heart failure and in the fatality rate of myocardial infarction. The effects on the incidence of coronary heart disease are only marginal at best. This disappointing finding has been ascribed to various factors: unwanted metabolie effects of anti hypertensive drugs, inadvertent drops in diastolic pressure interfering with coro nary perfusion, and, last but not least, failure to eliminate risk factors other than high blood pressure (smoking, alcohol abuse, lipid and glucose disturbanees, obesity, and the hemodynamic disadvantages of a sedentary life). Most of these additional noxious factors are refractory to drug treatment and call for modifica tion of life-style |
| Beschreibung: | 1 Online-Ressource (IX, 132 p) |
| ISBN: | 9783642747205 |
| DOI: | 10.1007/978-3-642-74720-5 |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV046144326 | ||
| 003 | DE-604 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190905s1990 xx o|||| 00||| eng d | ||
| 020 | |a 9783642747205 |9 978-3-642-74720-5 | ||
| 024 | 7 | |a 10.1007/978-3-642-74720-5 |2 doi | |
| 035 | |a (ZDB-2-SME)978-3-642-74720-5 | ||
| 035 | |a (OCoLC)1119148312 | ||
| 035 | |a (DE-599)BVBBV046144326 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.12 |2 23 | |
| 245 | 1 | 0 | |a Manual of Nonpharmacological Control of Hypertension |c edited by J. R. Viskoper |
| 264 | 1 | |a Berlin, Heidelberg |b Springer Berlin Heidelberg |c 1990 | |
| 300 | |a 1 Online-Ressource (IX, 132 p) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 520 | |a The prevention and correction of high blood pressure obviously is not an end in itself but a means of preventing cardiovascular complications. It is tempting to res ort to antihypertensive drugs, for the simple reason that current preparations are easy to dose and to take. There is a variety of reasons, however, to take advantage of the antihypertensive potential of nonpharmaco logical approaches first. For one thing, the use of tablets tends to accentuate the negative effects oflabelling a subject as hypertensive. The act oftaking tablets per se may elicit a spectrum of subjective adverse effects, as we have learned from placebo-controlled therapeutic trials. Even more importantly, the benefits of antihypertensive drug treatment are largely confined to the reduction of stroke and disease of the large vessels. With regard to incidence of cardiac events, some modest beneficial effects have been registered, such as a decrease in congestive heart failure and in the fatality rate of myocardial infarction. The effects on the incidence of coronary heart disease are only marginal at best. This disappointing finding has been ascribed to various factors: unwanted metabolie effects of anti hypertensive drugs, inadvertent drops in diastolic pressure interfering with coro nary perfusion, and, last but not least, failure to eliminate risk factors other than high blood pressure (smoking, alcohol abuse, lipid and glucose disturbanees, obesity, and the hemodynamic disadvantages of a sedentary life). Most of these additional noxious factors are refractory to drug treatment and call for modifica tion of life-style | ||
| 650 | 4 | |a Cardiology | |
| 650 | 4 | |a Rehabilitation | |
| 650 | 4 | |a Nephrology | |
| 650 | 4 | |a Cardiology | |
| 650 | 4 | |a Rehabilitation | |
| 650 | 4 | |a Nephrology | |
| 650 | 0 | 7 | |a Hypertonie |0 (DE-588)4026372-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Nichtmedikamentöse Therapie |0 (DE-588)4042113-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Compliance |g Patient |0 (DE-588)4130064-6 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Hypertonie |0 (DE-588)4026372-1 |D s |
| 689 | 0 | 1 | |a Nichtmedikamentöse Therapie |0 (DE-588)4042113-2 |D s |
| 689 | 0 | 2 | |a Compliance |g Patient |0 (DE-588)4130064-6 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Viskoper, J. R. |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783540510703 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783642747212 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-642-74720-5 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_1990/2004 | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-031524511 | |
| 966 | e | |u https://doi.org/10.1007/978-3-642-74720-5 |l DE-355 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1816412604097101824 |
|---|---|
| adam_text | |
| any_adam_object | |
| author2 | Viskoper, J. R. |
| author2_role | edt |
| author2_variant | j r v jr jrv |
| author_facet | Viskoper, J. R. |
| building | Verbundindex |
| bvnumber | BV046144326 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)978-3-642-74720-5 (OCoLC)1119148312 (DE-599)BVBBV046144326 |
| dewey-full | 616.12 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.12 |
| dewey-search | 616.12 |
| dewey-sort | 3616.12 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-3-642-74720-5 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000zc 4500</leader><controlfield tag="001">BV046144326</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1990 xx o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783642747205</subfield><subfield code="9">978-3-642-74720-5</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-642-74720-5</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-3-642-74720-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119148312</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046144326</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.12</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Manual of Nonpharmacological Control of Hypertension</subfield><subfield code="c">edited by J. R. Viskoper</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin, Heidelberg</subfield><subfield code="b">Springer Berlin Heidelberg</subfield><subfield code="c">1990</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (IX, 132 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The prevention and correction of high blood pressure obviously is not an end in itself but a means of preventing cardiovascular complications. It is tempting to res ort to antihypertensive drugs, for the simple reason that current preparations are easy to dose and to take. There is a variety of reasons, however, to take advantage of the antihypertensive potential of nonpharmaco logical approaches first. For one thing, the use of tablets tends to accentuate the negative effects oflabelling a subject as hypertensive. The act oftaking tablets per se may elicit a spectrum of subjective adverse effects, as we have learned from placebo-controlled therapeutic trials. Even more importantly, the benefits of antihypertensive drug treatment are largely confined to the reduction of stroke and disease of the large vessels. With regard to incidence of cardiac events, some modest beneficial effects have been registered, such as a decrease in congestive heart failure and in the fatality rate of myocardial infarction. The effects on the incidence of coronary heart disease are only marginal at best. This disappointing finding has been ascribed to various factors: unwanted metabolie effects of anti hypertensive drugs, inadvertent drops in diastolic pressure interfering with coro nary perfusion, and, last but not least, failure to eliminate risk factors other than high blood pressure (smoking, alcohol abuse, lipid and glucose disturbanees, obesity, and the hemodynamic disadvantages of a sedentary life). Most of these additional noxious factors are refractory to drug treatment and call for modifica tion of life-style</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Rehabilitation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nephrology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Rehabilitation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nephrology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hypertonie</subfield><subfield code="0">(DE-588)4026372-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Nichtmedikamentöse Therapie</subfield><subfield code="0">(DE-588)4042113-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Compliance</subfield><subfield code="g">Patient</subfield><subfield code="0">(DE-588)4130064-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Hypertonie</subfield><subfield code="0">(DE-588)4026372-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Nichtmedikamentöse Therapie</subfield><subfield code="0">(DE-588)4042113-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Compliance</subfield><subfield code="g">Patient</subfield><subfield code="0">(DE-588)4130064-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Viskoper, J. R.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783540510703</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783642747212</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-3-642-74720-5</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031524511</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-642-74720-5</subfield><subfield code="l">DE-355</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV046144326 |
| illustrated | Not Illustrated |
| indexdate | 2024-11-22T09:00:48Z |
| institution | BVB |
| isbn | 9783642747205 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031524511 |
| oclc_num | 1119148312 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (IX, 132 p) |
| psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
| publishDate | 1990 |
| publishDateSearch | 1990 |
| publishDateSort | 1990 |
| publisher | Springer Berlin Heidelberg |
| record_format | marc |
| spelling | Manual of Nonpharmacological Control of Hypertension edited by J. R. Viskoper Berlin, Heidelberg Springer Berlin Heidelberg 1990 1 Online-Ressource (IX, 132 p) txt rdacontent c rdamedia cr rdacarrier The prevention and correction of high blood pressure obviously is not an end in itself but a means of preventing cardiovascular complications. It is tempting to res ort to antihypertensive drugs, for the simple reason that current preparations are easy to dose and to take. There is a variety of reasons, however, to take advantage of the antihypertensive potential of nonpharmaco logical approaches first. For one thing, the use of tablets tends to accentuate the negative effects oflabelling a subject as hypertensive. The act oftaking tablets per se may elicit a spectrum of subjective adverse effects, as we have learned from placebo-controlled therapeutic trials. Even more importantly, the benefits of antihypertensive drug treatment are largely confined to the reduction of stroke and disease of the large vessels. With regard to incidence of cardiac events, some modest beneficial effects have been registered, such as a decrease in congestive heart failure and in the fatality rate of myocardial infarction. The effects on the incidence of coronary heart disease are only marginal at best. This disappointing finding has been ascribed to various factors: unwanted metabolie effects of anti hypertensive drugs, inadvertent drops in diastolic pressure interfering with coro nary perfusion, and, last but not least, failure to eliminate risk factors other than high blood pressure (smoking, alcohol abuse, lipid and glucose disturbanees, obesity, and the hemodynamic disadvantages of a sedentary life). Most of these additional noxious factors are refractory to drug treatment and call for modifica tion of life-style Cardiology Rehabilitation Nephrology Hypertonie (DE-588)4026372-1 gnd rswk-swf Nichtmedikamentöse Therapie (DE-588)4042113-2 gnd rswk-swf Compliance Patient (DE-588)4130064-6 gnd rswk-swf Hypertonie (DE-588)4026372-1 s Nichtmedikamentöse Therapie (DE-588)4042113-2 s Compliance Patient (DE-588)4130064-6 s DE-604 Viskoper, J. R. edt Erscheint auch als Druck-Ausgabe 9783540510703 Erscheint auch als Druck-Ausgabe 9783642747212 https://doi.org/10.1007/978-3-642-74720-5 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Manual of Nonpharmacological Control of Hypertension Cardiology Rehabilitation Nephrology Hypertonie (DE-588)4026372-1 gnd Nichtmedikamentöse Therapie (DE-588)4042113-2 gnd Compliance Patient (DE-588)4130064-6 gnd |
| subject_GND | (DE-588)4026372-1 (DE-588)4042113-2 (DE-588)4130064-6 |
| title | Manual of Nonpharmacological Control of Hypertension |
| title_auth | Manual of Nonpharmacological Control of Hypertension |
| title_exact_search | Manual of Nonpharmacological Control of Hypertension |
| title_full | Manual of Nonpharmacological Control of Hypertension edited by J. R. Viskoper |
| title_fullStr | Manual of Nonpharmacological Control of Hypertension edited by J. R. Viskoper |
| title_full_unstemmed | Manual of Nonpharmacological Control of Hypertension edited by J. R. Viskoper |
| title_short | Manual of Nonpharmacological Control of Hypertension |
| title_sort | manual of nonpharmacological control of hypertension |
| topic | Cardiology Rehabilitation Nephrology Hypertonie (DE-588)4026372-1 gnd Nichtmedikamentöse Therapie (DE-588)4042113-2 gnd Compliance Patient (DE-588)4130064-6 gnd |
| topic_facet | Cardiology Rehabilitation Nephrology Hypertonie Nichtmedikamentöse Therapie Compliance Patient |
| url | https://doi.org/10.1007/978-3-642-74720-5 |
| work_keys_str_mv | AT viskoperjr manualofnonpharmacologicalcontrolofhypertension |